Bausch+Lomb IPO Presentation Deck

Significant manufacturing capacity to support future growth Wilmington, MA Surgical Irvine, CA Manufacturing Manchester, MO Instruments St. Louis, MO R&D - Cataract / Vitreoretinal O'Fallon, MO Synergetics Rochester, NY Offices, R&D and manufacturing facility Lancaster, NY Alden specialty lenses Clearwater, FL Surgical / Vision Care BAUSCH+ LOMB Waterford, Ireland R&D and Manufacturing Facility Tampa, FL R&D, Manufacturing Worcestershire, England Greenville, SC 1. Investment reflects FY 2018-FY 2021 period Hastings, England Indaiatuba, Brazil Porto Alegre, Brazil Poland, Warsaw Aubenas, France Heidelberg, Germany Dr. Mann, Berlin, Germany Beijing, China Manufacturing Cheonan, South Korea R&D - Cosmetic Lenses Jinan, China Munich, Germany Technolas Perfect Vision Milan, Italy OUR PLATFORM • Global manufacturing base with 24 plants worldwide Vision Care / Consumer Invested -$727m in capital expenditures since 2018¹. Focused on modernizing, expanding capacity and building state-of-the-art manufacturing capabilities to meet needs of next generation pipeline products Internally manufacture key products which comprise a significant portion of overall portfolio . Additional partnerships with high quality third-party manufacturers Long track record of excellence in manufacturing based on the highest production and regulatory standards Ophthalmic Pharmaceuticals Surgical 58

View entire presentation